Researchers have discovered a link between specific neural circuits to distinct behavioral symptoms of depression. The study, published in Cell, reports altering the networks helped to improve symptoms such as social withdrawal and helplessness.
Researchers have identified increased inflammatory activation markers in the brains of people with major depressive disorder who report suicidal ideations. The findings support recent research that anti-inflammatories may provide antidepressant effects for some patients.
Researchers report the hypothalamus is, on average, five percent larger in those with mood disorders like major depressive disorder and bipolar disorder, than it is in those without depression.
A new study reveals neuroimaging may prove useful in revealing patients with depression who may respond well to psychotherapy.
Transcranial alternating current brain stimulation (tACS) significantly reduced symptoms in people diagnosed with major depressive disorder in a pilot clinical trial.
According to researchers, 40% of people with treatment resistant depression who received rTMS no longer had suicidal thoughts following treatment.
Comparing data from multiple neuroimaging studies, researchers found shared brain structural abnormalities between four psychiatric disorders, including schizophrenia and bipolar disorder. They also identified brain signatures unique to each condition.
A new mouse study reveals females have a three fold higher abundance of EP3, in addition to elevated levels of genes associated with major depressive disorder in the locus coeruleus.
Study finds an association between resting state network connectivity abnormalities in those with major depressive disorder who experienced childhood trauma.
Findings reveal it is possible to predict the risk of a person with MDD lapsing back into depression after stopping antidepressants. Those who relapse take longer to decide how much effort to invest for a reward.